IRIS
GIACOMETTI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.522
EU - Europa 5.553
AS - Asia 1.345
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 9
OC - Oceania 3
AF - Africa 1
Totale 17.445
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.492
UA - Ucraina 1.452
IE - Irlanda 822
SE - Svezia 777
IT - Italia 718
TR - Turchia 684
DE - Germania 625
DK - Danimarca 530
FI - Finlandia 298
KR - Corea 278
SG - Singapore 257
GB - Regno Unito 168
FR - Francia 72
CN - Cina 64
CA - Canada 28
IN - India 28
IR - Iran 24
BE - Belgio 22
NL - Olanda 16
EU - Europa 11
RU - Federazione Russa 11
RO - Romania 9
RS - Serbia 9
CH - Svizzera 7
PL - Polonia 5
BG - Bulgaria 4
CL - Cile 4
JP - Giappone 4
AR - Argentina 3
AT - Austria 3
MY - Malesia 3
AU - Australia 2
HK - Hong Kong 2
HR - Croazia 2
MX - Messico 2
A1 - Anonimo 1
BR - Brasile 1
CI - Costa d'Avorio 1
CO - Colombia 1
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
NZ - Nuova Zelanda 1
Totale 17.445
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.483
Chandler 1.172
Fairfield 1.116
Dublin 812
Ashburn 584
Wilmington 583
Woodbridge 485
Boardman 413
Houston 384
Seattle 370
Ann Arbor 367
Des Moines 365
New York 364
Cambridge 334
Lawrence 316
Princeton 316
San Mateo 311
San Diego 142
Centro 131
Turin 114
Redmond 67
Beijing 46
Norwalk 43
Izmir 40
London 36
Porto 27
Washington 26
Helsinki 25
Los Angeles 25
Pune 24
Brussels 22
Falls Church 21
Ottawa 19
Marche 17
Kilburn 15
Rome 15
Civitanova Marche 14
Ancona 13
Cingoli 12
Istia D'ombrone 11
Prescot 10
Saint Louis 10
Belgrade 9
Nanjing 9
North Bergen 9
Dronten 8
Buffalo 7
Chiswick 7
Hounslow 7
Auburn Hills 6
Fort Worth 6
Mcallen 6
Pergola 6
Pesaro 6
Acton 5
Hanover 5
Jesi 5
Moscow 5
San Benedetto del Tronto 5
Amsterdam 4
Boydton 4
Campobasso 4
Castelfiorentino 4
Dallas 4
New Bedfont 4
Santa Vittoria In Matenano 4
Squinzano 4
Tolentino 4
Toronto 4
Vallefoglia 4
Venice 4
Andover 3
Appignano 3
Breda Di Piave 3
Gdansk 3
Guangzhou 3
Milan 3
Napoli 3
Palermo 3
Perugia 3
Petaling Jaya 3
San Jose 3
Serra 3
Vienna 3
Zurich 3
Arco 2
Birmingham 2
Cava De' Tirreni 2
Central 2
Chiaravalle 2
Corridonia 2
Falconara Marittima 2
Fermo 2
Fiesole 2
Frankfurt am Main 2
Jamaica 2
La Canada Flintridge 2
Macerata 2
Meppel 2
Monterrey 2
Totale 10.931
Salva come PNG Salva come JPEG
Nome #
Antimicrobial Resistance: A Challenge for the Future 143
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 123
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 109
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 108
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound 106
Anticryptosporidial activity of paromomycin. 101
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 97
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 94
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 94
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 93
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. 92
Tigecycline accelerates staphylococcal infected burn wound helaing through MMP-9 modlualtion 91
Antimicrobial activity of polycationic peptides 89
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 88
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. 86
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 84
SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region 84
In-vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. 83
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 82
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 82
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis 81
Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats 81
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 80
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 80
Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa sepsis 80
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 79
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy 79
Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors. 78
Epidemiology and microbiology of surgical wound infections. 78
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 78
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 78
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): A multicohort collaboration 78
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients 78
The Antimicrobial Peptide Tachyplesin III Coated alone and in Combination with Intraperitoneal Piperacillin-Tazobactam Prevents Ureteral Stent Biofilm Formation in a Rat Subcutaneous Pouch Model of Pseudomonas Infection. 77
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 76
In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds 76
ACTIVITY OF THE NEW ANTIFUNGAL TRIAZOLE, POSACONAZOLE, AGAINST CRYPTOCOCCUS NEOFORMANS 75
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 75
In-vitro activity of rifabutin and albendazolo singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. 74
In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum. 74
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 74
Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors 74
Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates 74
In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans. 73
The antimicrobial peptide Tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model 73
Tocilizumab in COVID-19 interstitial pneumonia 73
Urinary catheters and biofilm formation 71
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 70
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 70
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 70
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 70
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 70
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 70
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 69
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 69
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 68
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 68
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 68
Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study 68
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 67
Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy. 67
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 67
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 67
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 67
Delayed wound healing in aged skin rat models after thermal injury is associated with an increased MMP-9, K6 and CD44 expression 67
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 67
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 66
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 66
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 66
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 66
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients 66
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 66
whISOBAX™ inhibits bacterial pathogenesis and enhances the effect of antibiotics 66
OpuC--an ABC transporter that is associated with Staphylococcus aureus pathogenesis. 65
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 65
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. 65
An (Italian) proposal for a comprehensive approach to infections across the surgical pathway 65
Long-term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multi-centre cohort of HIV-1-infected, virologically suppressed patients 65
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. 64
Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure. 64
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 64
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 64
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 64
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 64
In- vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii. 64
The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection 64
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 64
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50cp/mL. 64
Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy 64
Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in a animal model of ureteral stent infection. 63
Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin resistant Staphylococcus aureus. 63
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 63
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 63
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 63
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 63
Quorum Sensing Inhibitor FS3-coated Vascular Graft Enhances Daptomycin Efficacy in a Rat Model of Staphylococcal Biofilm Infection. 63
Psoriasi e AIDS. A proposito di un caso. 62
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 62
In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics. 62
Durability and tolerability of long-term nevirapine-based HAART. 62
Totale 7.475
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.777
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201964 0 0 0 0 0 0 0 0 0 0 6 58
2019/20201.855 22 1 304 10 313 21 308 18 315 62 52 429
2020/20214.586 245 474 609 62 499 297 431 304 473 482 477 233
2021/20222.519 215 537 25 124 33 174 125 150 165 299 193 479
2022/20233.991 417 370 296 275 283 652 7 209 1.030 20 305 127
2023/20242.030 433 48 139 383 408 471 34 63 21 28 2 0
Totale 17.804